Early Access

Your health, monitored
24/7 — no device required.

Tapas.one HealthOS is the world's first skin-native biosensing platform. Apply a nano-cream, and our AI reads your heart rate, stress, inflammation, and recovery — continuously, invisibly, and personally. Join the early access waitlist to be first in line.

No spam. No hardware required yet. We will only contact you about early access.

Why join early?

Early adopters are not just users — they are co-creators of the platform.

🎯
Shape the product
Direct input into feature development, sensing modalities, and the AI Health Engine roadmap
🔬
First access to data
Be among the first to receive your Personal Health Twin profile and longitudinal biosignal data
💬
Founder access
Direct communication channel with Eangelica and Pau throughout the pilot program
🏆
Founding member status
Permanently recognized as a founding member with lifetime pricing and exclusive benefits
📊
Research contribution
Contribute to the longitudinal dataset that will power clinical validation studies
🤝
Community
Join a curated community of high-performance individuals pioneering the future of personal health
StartX · Stanford Ecosystem

A new category of health technology

Tapas.one is applying to StartX — Stanford's non-profit accelerator — in June 2026. We are building at the intersection of nano-material science, AI health intelligence, and clinical medicine, creating a category that does not yet exist.

Today, you only know your health when something goes wrong. Tapas.one changes that: continuous biosensing through a skin-applied nano-cream, powered by an AI engine that learns your biology over time and alerts you before problems arise.

Non-profit accelerator with no equity taken
Stanford faculty and alumni network
Clinical and regulatory advisory access
Deep tech investor community
01

The invention

Pau Sabater's nano-cream biosensing formulation — a patentable, skin-native sensing medium that captures multimodal biological signals without hardware constraints.

02

The intelligence

Eangelica Aton's clinical AI architecture — a health intelligence engine that transforms raw biosignals into personalized, predictive health insights.

03

The platform

A complete HealthOS stack — from skin to insight — that creates compounding data advantages and a Personal Health Twin for every user.

For Investors

Request the investor deck

We are raising a pre-seed round to fund clinical validation and the first manufacturing run of the nano-cream formulation. If you are an investor interested in deep-tech health infrastructure, we would love to connect.

We respond to all investor inquiries within 48 hours.

A note from the founders
Eangelica Aton & Pau Sabater

"We started Tapas.one because we believe the most important healthcare revolution is not happening in hospitals — it is happening at the interface between AI and human biology.

Pau's nano-cream invention opened a door that nobody else has walked through: the ability to sense the body continuously, intimately, and without hardware constraints. Combined with AI-native health intelligence, we can build something that has never existed before — a living digital model of your unique biology.

We are looking for early adopters who share this vision. People who want to understand their biology deeply, who are willing to be part of building something genuinely new, and who believe that the future of healthcare is continuous, personalized, and invisible."

Eangelica Aton·Clinical AI & Health Intelligence
Pau Sabater·Nano-Material Science & Sensing